openPR Logo
Press release

Global Anti-Obesity Drugs Market Analysis and Forecast, 2019-2028

05-24-2023 09:00 AM CET | Health & Medicine

Press release from: RationalStat LLC

Anti-Obesity Drugs Market

Anti-Obesity Drugs Market

The global anti-obesity drugs market is estimated at US$ 1.7 billion in 2022 and is expected to grow at a significant CAGR of over 17% over the forecast period of 2019-2028.

Market Scope and Report Overview

According to a deep-dive market assessment by RationalStat, the global anti-obesity drugs market has been analyzed on the basis of market segments, including type, distribution channel, and geography/regions (incl. North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of2019-2028.

Market intelligence for the global anti-obesity drugs market covers market sizes on the basis of market value (US$/EUR Million) and volume ('000 units/tons/liters) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.

In addition, the long-term sector and products/services 10-year outlook and its implications on the anti-obesity drugs market. It also includes the industry's current state - Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Period Covered include data for 2019-2028 along with year-wise demand estimations

The anti-obesity drugs market report analyzes the market on the basis of global economic situations, regional geopolitics, import-export scenarios, trade duties, market developments, organic and inorganic strategies, mergers and acquisitions, product launches, government policies, new capacity addition, technological advancements, R&D investments, and new market entry, replacement rates, penetration rates, installed base/fleet size, global and regional production capacity, among others.

RationalStat offers market analysis and consulting studies on the basis of dedicated and robust desk/secondary research supported by a strong in-house data repository. In addition, the research leverages data based on the real-time insights gathered from primary interviews. Market estimations and insights are based on primary research (covering more than 240 entities) and secondary research by leveraging international benchmarking.

The global anti-obesity drugs market report also covers value chain and supply chain analysis that provides in-depth information about the value chain margins and the role of various stakeholders across the value chain. Market dynamics provided in the market study include market drivers, restraints/challenges, trends, and their impact on the market throughout the analysis period.

In the competition analysis section, the global anti-obesity drugs market provides a detailed competition benchmarking analysis based on the market share of the leading companies/brands/ producers/suppliers, a market structure overview with detailed company profiles of more than 25 players with their financials, product/service offerings, major developments, business models, etc. This enables, clients and report buyers to make strong, precise, and timely decisions.

Explore more about this report - Request for Sample and Scope of the Study
https://store.rationalstat.com/store/global-anti-obesity-drugs-market/#tab-ux_global_tab

Macroeconomic Scenario and the Impact of COVID-19 on Regional Economic Sentiment

In the latest RationalStat analysis, geopolitical conflicts and inflation are the cited economic risks, while concerns about the volatility across energy sectors prevail in Europe and other parts of the world. Some of the potential risks to the economic growth in the leading regions, including Asia Pacific, Europe, North America, the Middle East & Africa, and other developing regions, are inflation, volatile energy prices, supply chain disruptions, geopolitical instability, labor shortages, rising interest rates, and COVID-19 pandemic.

The global economy experienced heavy headwinds, throughout 2019-2021, as some countries witnessed subdued growth, while other countries continued to grapple with economic slowdowns. The COVID-19 pandemic has levied undue pressure across the majority of industries globally and has caused a major economic crisis in the US, India, Italy, the UK, Germany, India, Japan, South Korea, the UK, and many others. Besides, the exit of the UK from the European Union earlier in 2020 and the Russo-Ukraine war in 2022 exacerbated the ever-heightened global uncertainty.

In addition to this, the global economic growth slowed in 2022 to 3.3%, weaker than expected at the end of 2021, mainly weighed down by Russia's war in Ukraine and the associated cost-of-living crisis in many countries. However, improvement in economic activities during the forecast period is expected. Growth is projected to remain at lower rates in 2023 and 2024, at 2.6% and 2.9% respectively.

Competition Analysis and Market Structure

Some of the prominent players that contribute significantly to the anti-obesity drugs market growth include Novo Nordisk A/S, GlaxoSmithKline plc, VIVUS LLC, Currax Pharmaceuticals LLC, Hoffamann-La Roche Ltd., Pfizer Inc., Sandoz International GmbH, Boehringer Ingelheim International GmbH, Arena Pharmaceuticals Inc., Takeda Pharmaceuticals Company Ltd., Merck & Co. Inc., Eisai Co. Ltd., Novo Nordisk A/S and among others.

RationalStat has segmented the global anti-obesity drugs market based on type, distribution channel, and region
• Global Anti-Obesity Drugs Market Value (US$ Million), Volume ('000 units/tons), and Market Share (2019-2028) Analysis by Type
o Prescription Drugs
o OTC Drugs
• Global Anti-Obesity Drugs Market Value (US$ Million), Volume ('000 units/tons), and Market Share (2019-2028) Analysis by Distribution Channel
o Hospital Pharmacy
o Retail and Online Pharmacy
o Others
• Global Anti-Obesity Drugs Market Value (US$ Million), Volume ('000 units/tons), and Market Share (2019-2028) Analysis by Region
o North America Anti-Obesity Drugs Market
 US
 Canada
o Latin America Anti-Obesity Drugs Market
 Brazil
 Mexico
 Rest of Latin America
o Western Europe Anti-Obesity Drugs Market
 Germany
 UK
 France
 Spain
 Italy
 Benelux
 Nordic
 Rest of Western Europe
o Eastern Europe Anti-Obesity Drugs Market
 Russia
 Poland
 Hungary
 Other CIS Countries
 Rest of Eastern Europe
o Asia Pacific Anti-Obesity Drugs Market
 China
 Japan
 India
 South Korea
 Australia
 ASEAN
• Indonesia
• Thailand
• Philippines
• Vietnam
• Malaysia
• Rest of ASEAN
 Rest of Asia Pacific
o Middle East & Africa Anti-Obesity Drugs Market
 GCC
• Saudi Arabia (KSA)
• United Arab Emirates (UAE)
• Rest of the GCC
 South Africa
 Nigeria
 Turkey
 Rest of the Middle East & Africa

• Leading Companies and Market Players
o Novo Nordisk A/S
o GlaxoSmithKline plc
o VIVUS LLC
o Currax Pharmaceuticals LLC
o Hoffamann-La Roche Ltd.
o Pfizer Inc.
o Sandoz International GmbH
o Boehringer Ingelheim International GmbH
o Arena Pharmaceuticals Inc.
o Takeda Pharmaceuticals Company Ltd.
o Merck & Co. Inc.
o Eisai Co. Ltd.
o Novo Nordisk A/S

For more information about this report https://store.rationalstat.com/store/global-anti-obesity-drugs-market/

Key Questions Answered in the Anti-Obesity Drugs Report:
• What will be the market value of the global anti-obesity drugs market by 2028?
• What is the market size of the global anti-obesity drugs market?
• What are the market drivers of the global anti-obesity drugs market?
• What are the key trends in the global anti-obesity drugs market?
• Which is the leading region in the global anti-obesity drugs market?
• What are the major companies operating in the global anti-obesity drugs market?
• What are the market shares by key segments in the global anti-obesity drugs market?

Kimberly Shaw,
Content and Press Manager
RationalStat LLC
sales@rationalstat.com
Phone: +1 302 803 5429

RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client's needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anti-Obesity Drugs Market Analysis and Forecast, 2019-2028 here

News-ID: 3064562 • Views:

More Releases from RationalStat LLC

Latest Market Study | Global Lipstick Filling Machine Market Size, Share, & Forecast 2023-2030
Latest Market Study | Global Lipstick Filling Machine Market Size, Share, & Fore …
The global lipstick filling machine market is expected to reach US$ 88.2 million by 2030, with an annual growth rate of more than 4.5%. According to RationalStat's recent industry analysis, the Global Lipstick Filling Machine Market value is estimated at US$ 64.8 million in 2023 and is expected to rise at a strong CAGR of over 4.5% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview A lipstick
Published Market Report | Global Railway Systems Market Size, Share, & Forecast 2023-2030
Published Market Report | Global Railway Systems Market Size, Share, & Forecast …
The global railway systems market is expected to reach US$ 29.2 billion by 2030, with an annual growth rate of more than 3.6%. According to RationalStat's recent industry analysis, the Global Railway Systems Market value is estimated at US$ 22.8 billion in 2023 and is expected to rise at a strong CAGR of over 3.6% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview Railway systems, also known
Published Market Report | Global Window Blinds Market Size, Share, & Forecast 2023-2030
Published Market Report | Global Window Blinds Market Size, Share, & Forecast 20 …
The global window blinds market is expected to reach US$ 3.7 billion by 2030, with an annual growth rate of more than 3.8%. According to RationalStat's most recent industry analysis, the Global Window Blinds Market value is estimated at US$ 2.9 billion in 2023 and is expected to rise at a strong CAGR of over 3.8% over the forecast period of 2023-2030. Market Definition, Market Scope, and Report Overview Window blinds are
Ointment and Cream Manufacturing Plant Market Report 2023 | Ointment and Cream Manufacturing Plant Market Analysis, Trends, Growth Opportunities, and Forecast, 2023-2030
Ointment and Cream Manufacturing Plant Market Report 2023 | Ointment and Cream M …
The global ointment and cream manufacturing plant market is expected to approach US$ 388.7 million by 2030, with an annual growth rate of more than 5.9% Global Ointment and Cream Manufacturing Plant Market is valued at US$ 260.9 million in 2023 and is expected to grow at a significant CAGR of over 5.9% over the forecast period of 2023-2030, according to the published market report by RationalStat Market Definition, Market

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$